Comparative associations of adiposity measures with cardiometabolic risk burden in asymptomatic subjects

Atherosclerosis
Nathalie DervauxAlain Simon

Abstract

Obesity increases the risk of cardiovascular diseases and diabetes. To determine which measure of adiposity, body mass index (BMI), waist circumference (WC) or body fat mass (BFM) is the most predictive of the coronary heart disease (CHD) risk and of the presence of the metabolic syndrome. A cross-sectional study of 649 consecutive men and women aged 22-79 years, in primary prevention. BMI, WC and BFM were strongly associated with conventional cardiometabolic risk factors. For a 1-S.D. increase in BMI, WC and BFM, the odds ratios (95% CIs) of having the metabolic syndrome after adjustment for age, gender, and drug treatments were as follows: BMI, 3.40 (2.68-4.37); WC, 4.79 (3.61-6.53); and BFM, 3.19 (2.49-4.16). WC annihilated the association of BMI and BFM with the metabolic syndrome when measures of adiposity were introduced two by two. For CHD risk, the odds ratios (95% CIs) were as follows: 1.62 (1.16-2.24), 1.72 (1.22-2.42), and 1.92 (1.40-2.62) respectively. BFM annihilated the associations of BMI and WC with CHD risk when measures of adiposity were introduced two by two. WC shows the best association with the metabolic syndrome, while BFM shows the best association with high CHD risk. BMI shows weaker relationships with ...Continue Reading

References

May 1, 1995·American Journal of Public Health·R RoubenoffP W Wilson
May 29, 1998·Circulation·P W WilsonW B Kannel
Mar 27, 1999·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·J L MegnienJ Levenson
Oct 8, 1999·The New England Journal of Medicine·E E CalleC W Heath
Mar 27, 2001·BMJ : British Medical Journal·J P DesprésD Prud'homme
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Dec 6, 2006·Journal of Atherosclerosis and Thrombosis·Junji KobayashiHiroshi Mabuchi

❮ Previous
Next ❯

Citations

Aug 10, 2013·Reviews in Endocrine & Metabolic Disorders·Catherine M Phillips
May 19, 2011·International Journal of Obesity : Journal of the International Association for the Study of Obesity·J Gómez-AmbrosiG Frühbeck
Oct 26, 2010·European Heart Journal·Emanuela FalaschettiJohn E Deanfield
Sep 18, 2012·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Sareen S GropperPamela V Ulrich
Jan 11, 2012·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·S B van DijkH Wittink
Mar 4, 2014·The Journal of the Association of Nurses in AIDS Care : JANAC·María José Míguez-BurbanoAsthana Deshratan
Oct 11, 2012·Journal of Obesity·Sareen S GropperPamela V Ulrich
Jan 29, 2016·BMC Public Health·Vicente MartínUNKNOWN CIBERESP Cases and Controls in Pandemic Influenza Working Group, Spain
Jun 4, 2013·Transplantation Proceedings·K TokodaiA Nakamura
May 3, 2013·Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association·R BaudrandM Moreno
Feb 22, 2011·The Psychiatric Clinics of North America·Rohan Ganguli, Martin Strassnig
May 3, 2015·Nutrition·Aline de Castro PimentelRonir Raggio Luiz
Jun 14, 2013·International Journal of Endocrinology·Franciane Rocha FariaSilvia Eloiza Priore
Apr 26, 2016·The Journal of the Egyptian Public Health Association·Hoda I I Rizk, Nesreen M Kamal Elden
Jan 28, 2014·Current Therapeutic Research, Clinical and Experimental·Hua WangBo Feng
Jun 7, 2017·Metabolic Syndrome and Related Disorders·Lars LindErik Lampa
Nov 1, 2018·Korean journal of family medicine·Gyu Lee KimA Rum Park

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.